ASCENDIS PHARMA A/S shareholders Q2 2023

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q2 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.

ASCENDIS PHARMA A/S shareholders Q2 2023
NameSharesValueWeighting ↓
RA Capital Management 11,225,357$1,001,863,11218.92%
Q Global Advisors, LLC 195,000$17,40412.55%
Sofinnova Investments, Inc. 754,032$67,297,3564.41%
Avoro Capital Advisors LLC 3,580,555$319,564,5344.34%
Finepoint Capital LP 139,772$12,474,6514.32%
Spyglass Capital Management LLC 657,853$58,713,3804.24%
Saturn V Capital Management LP 78,442$7,000,9483.88%
DAFNA Capital Management LLC 135,212$12,067,6713.30%
ARS Investment Partners, LLC 289,860$25,870,0053.02%
Ghost Tree Capital, LLC 100,000$8,925,0002.95%
Resolute Capital Asset Partners LLC 37,500$3,3472.38%
WESTFIELD CAPITAL MANAGEMENT CO LP 3,631,712$324,130,2682.06%
Evolutionary Tree Capital Management, LLC 16,947$1,512,5201.82%
Affinity Asset Advisors, LLC 57,760$5,155,0801.80%
Matisse Capital 31,950$2,851,5381.77%
Nicholas Investment Partners, LP 170,609$15,226,8531.04%
TimesSquare Capital Management, LLC 767,427$68,4930.98%
Henry James International Management Inc. 24,495$2,186,1790.95%
Rock Springs Capital Management LP 425,500$37,975,8750.90%
Artisan Partners Limited Partnership 6,222,451$555,353,7520.89%
External links

This page lists ASCENDIS PHARMA A/S's shareholders in Q2 2023. To view ASCENDIS PHARMA A/S's shareholder history, click here.